SADC Regional Assessment Report of Policies and Programmes on Child and Adolescent HIV, TB and Malaria - 2011-2012
Member States (MS) of the Southern African Development Community (SADC) have made important progress in the last decades in reducing child mortality. However, with children under 18 years old representing 48% of the total population in the SADC region, child survival and development remains a key challenge. HIV, TB and malaria are important sources of morbidity and mortality in children. In 2009, there were more than 1 million children under the age of 15 years estimated to be living with HIV within SADC Member States, and in 2010 mother to child transmission of HIV (MTCT) resulted in more than 176,000 new infant infections in the region, with the percentage of MTCT across Member States ranging from 3 to 37%.
Since the 2009 Lancet Health in South Africa Series, important changes have occurred in the country, resulting in an
increase in life expectancy to 60 years. Historical injustices together with the disastrous health policies of the previous
administration are being transformed. The change in leadership of the Ministry of Health has been key, but new
momentum is inhibited by stasis within the health management bureaucracy. Specific policy and programme changes
are evident for all four of the so-called colliding epidemics: HIV and tuberculosis; chronic illness and mental health;
injury and violence; and maternal, neonatal, and child health. South Africa now has the world’s largest programme of
Tracking Global Commitments on AIDS
In 2011, ONE and many of our partners including NGOs, thought leaders, and scientists rallied around the idea that we could see the “beginning of the end of AIDS” in our lifetimes. We highlighted this opportunity as part of our ongoing AIDS campaign work and celebrated when a number of world leaders and influentials came together on World AIDS Day 2011 to champion this vision.
Memorandum: Initiation of ARV's to HIV positive children 5 years and under irrespective of CD4 count or WHO clinical staging
Please find the circular regarding the initiation of ARV's to HIV positive children 5 years and under irrespective of CD4 count and WHO clinical staging. Please note that this change is effective immediately and this must be communicated to, and implemented by all initiating facilities including those that are run by partners.
Even though it’s preventable and treatable, tuberculosis (TB) is a top ten killer of children worldwide.
ACTION has released its second brief on children and TB, issuing recommendations for the international community and affected countries to combat this neglected epidemic.
Since ACTION released its first Childhood TB brief last year, the global community has paid attention.
But we need to keep the momentum going. Children are still misdiagnosed, unaccounted for, and lack access to appropriate pediatric TB drugs.
Making it work: Lessons learnt from three regional workshops to integrate human rights into national HIV strategic plans
To strengthen the rights-based national response to HIV, the Joint United Nations Programme on HIV/AIDS (UNAIDS), with the technical support of the International HIV/AIDS Alliance (the Alliance), initiated a project in 2011 to help national stakeholders (national AIDS programme managers, officials from ministries of health, gender and justice, civil society representatives, members of affected communities and UN staff) integrate human rights programmes into National Strategic Plans (NSPs). This brief report outlines some short term outcomes and lessons learnt from this initiative.
A Rapid Mortality Surveillance (RMS) system was established to monitor the trend in the number of deaths recorded on the national population register at a time when there was a substantial time lag in the cause-of-death reports being produced by Stats SA. This report presents an analysis of the RMS data and provides empirical estimates of the mortality-based high-level indicators for Outputs 1 and 2 of the health-related outcomes of the NSDA to highlight the significant changes in mortality currently taking place in South Africa. By adjusting for known bias in the RMS data, it is possible to provide information about these key indicators two years sooner than the published vital registration data.
This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and ﬁnancing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.
It is my pleasure to introduce the third edition of the Standard Treatment Guidelines and Essential Medicines List for Hospital Level. This edition marks the culmination of an intense and thorough review process.
The Standard Treatment Guidelines have been aligned with current developments in medicine and scientifi c advances. Clinical evidence was used in the selection of medicines. In addition, prevailing medicine cost, affordability, as well as practice implications were taken into consideration. Furthermore, harmonisation with priority guidelines within the Department of Health has also been attained.